Weiner M
Res Commun Chem Pathol Pharmacol. 1980 Sep;29(3):561-71.
The in vitro effects of prostaglandin A1 and prostaglandin E1 on the hepatic microsomal metabolism of type I (aminopyrine) and type II (p-chloro-N-methylaniline and aniline) drug substrates in rabbits were investigated. Both prostaglandins competitively inhibited aminopyrine N-demethylation to the same extent with a 500 microM prostaglandin concentration decreasing metabolism by approximately 50 percent. Prostaglandin A1 and prostaglandin F1 decreased p-chloro-N-methylaniline biotransformation, and prostaglandin E1 depressed aniline metabolims, via mixed-inhibition kinetics. The degree of inhibition was greatest with aniline as substrate. Aniline (0.125 mM) metabolism was inhibitied 49 percent and 71 percent by 100 microM and 500 microM prostaglandin E1, respectively.
研究了前列腺素A1和前列腺素E1对兔体内I型(氨基比林)和II型(对氯-N-甲基苯胺和苯胺)药物底物肝微粒体代谢的体外作用。两种前列腺素均以相同程度竞争性抑制氨基比林N-脱甲基作用,500微摩尔的前列腺素浓度可使代谢降低约50%。前列腺素A1和前列腺素F1通过混合抑制动力学降低对氯-N-甲基苯胺的生物转化,前列腺素E1则抑制苯胺代谢。以苯胺作为底物时抑制程度最大。100微摩尔和500微摩尔的前列腺素E1分别使苯胺(0.125毫摩尔)代谢抑制49%和71%。